Patent ID: 11904057
Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  B | IPC A  B

Claim 10:
11. The peptide hydrogel of claim 10, wherein the nucleic acid molecule is any one of:
hsa-miR-1, hsa-miR-7, hsa-miR-10a, hsa-miR-15, hsa-miR-16, hsa-miR-23a-3p, hsa-miR-24-1, hsa-miR-24-2-5p, hsa-miR-26a, hsa-miR-26b, hsa-miR-27a-5p, hsa-miR-27b-5p, hsa-miR-27b-3p, hsa-miR-29a, hsa-miR-29b, hsa-miR-29c, hsa-miR-30b-5p, hsa-miR-30c-1, hsa-miR-33a, hsa-miR-34a, hsa-miR-95, hsa-miR-96, hsa-miR-100, hsa-miR-125a, hsa-miR-127, hsa-miR-130a, hsa-miR-130b, hsa-miR-132-3p, hsa-miR-133b, hsa-miR-134, hsa-miR-135a-1, hsa-miR-136, hsa-miR-139, hsa-miR-143, hsa-miR-145, hsa-miR-148a, hsa-miR-149, hsa-miR-181c, hsa-miR-181d, hsa-miR-182, hsa-mir-183, hsa-miR-190, hsa-miR-190b, hsa-miR-192, hsa-miR-195, hsa-miR-194, hsa-miR-200, hsa-miR-206, hsa-miR-212, hsa-miR-215, hsa-miR-221, hsa-miR-222-3p, hsa-miR-320d-1, hsa-miR-342, hsa-miR-370, hsa-miR-375, hsa-miR-376a-1, hsa-miR-376b, hsa-miR-491, hsa-miR-497, hsa-miR-502, hsa-miR-506, hsa-miR-509-1, hsa-miR-548, hsa-miR-643, hsa-miR-653, hsa-miR-664, hsa-miR-668, hsa-miR-676, hsa-miR-939, hsa-miR-1245, hsa-miR-1287, hsa-miR-1293, hsa-miR-1294, hsa-miR-1538, hsa-miR-2114, hsa-miR-3145, hsa-miR-3610, hsa-miR-3677, hsa-let-7c-5p, hsa-miR-590-3p, hsa-miR-4472-1, hsa-miR-8078, hsa-miR-4675, hsa-mir-155, hsa-mir-196b, hsa-mir-4524a, or hsa-mir-4524b; or
a mimic and/or mimetic thereof.